BioCentury | Jan 11, 2017
Distillery Therapeutics

Infectious disease

...INDICATION: Hepatitis C virus (HCV) Cell culture studies identified cajanine and its analogs as CSGALNACT1 inhibitors...
...HCV infection. A human hepatoma cell line-based mRNA assay identified cajanine as an inhibitor of CSGALNACT1...
...Sciences Inc. and Mylan N.V. market the HCV NS5B polymerase inhibitor Sovaldi for HCV. TARGET/MARKER/PATHWAY: Chondroitin sulfate N-acetylgalactosaminyltransferase 1 (CSGALNACT1)...
Items per page:
1 - 1 of 1